OBJECTIVES: Current surgical procedures lack high-sensitivity intraoperative imaging guidance, leading to undetected micro tumours. In vivo near-infrared (NIR) fluorescence imaging provides a powerful tool for identifying small nodules. The aim of this study was to examine our experience of using 2 different NIR devices in pulmonary resection surgery.
INTRODUCTION
Lung cancer is the most common cancer type and the leading cause of cancer death in China [1] . Up to 15% of lung cancer patients develop synchronous or metachronous nodules [2, 3] . Meanwhile, when dealing with pulmonary metastasis tumours of other malignancies, the detection of all nodules is also challenging. Failure to remove all of the micro lesions during surgery might be one of the causes of recurrence. With the widespread use of video-assisted thoracoscopic surgery (VATS), manual palpation of pulmonary nodules is restricted; surgeons have to rely on visual inspection. However, white-light imaging as the primary intraoperative imaging method lacks the contrast between tumours and normal tissue [4] . For the current clinical imaging methods, superficially multiple micro lesions with a diameter of <5 mm are particularly difficult to detect [5] . Thus, patients with lung nodules need a new imaging technology to better identify small lung lesions and guide surgery in real time [6] .
Fluorescence image-guided surgery is a highly sensitive and specific imaging method that has the potential to identify imperceptible lesions [7] [8] [9] . Currently, the most widely used NIR fluorescence dye is indocyanine green (ICG) (excitation: 778 nm and emission: 830 nm), which was approved by the Food and Drug Administration (FDA). The ICG is a very safe imaging agent that has few allergic reactions (approximately 0.003%) and is applied in various tumour detection because of its passive accumulation †The first four authors contributed equally to this work. [10] . Several groups have proved the feasibility and benefits of near-infrared (NIR) fluorescence image-guided surgery in tumour nodules detection [11] [12] [13] [14] [15] [16] . van Dam et al. showed that the use of fluorescence imaging technology detected significantly additional tumour nodules in ovarian cancer surgery [17] . Liberale et al. showed that NIR image-guided surgery discovered a higher number of subclinical lesions than conventional inspection for peritoneal carcinomatosis [18] . Moreover, Okusanya et al. performed open surgeries of lung cancer and successfully confirmed that ICG could remain in tumours 24 h after intravenous injection by enhanced permeability and retention (EPR) effect. They detected 5 additional non-palpable nodules guided by NIR fluorescence imaging [19] . Compared with open surgery, the treatment of lung cancer with VATS showed an urgent demand for fluorescence imaging guidance due to less manual palpation and more undiscovered additional nodules [20, 21] . However, research in this field has been restricted due to the lack of high-sensitivity fluorescence thoracoscopic systems. To satisfy this need, we developed a novel ultrasensitive fluorescence thoracoscopic system (SUPEREYE) that offers high-fluorescence collection efficiency and accurate registration. High sensitivity of imaging systems collects weak signals of small tumours. Furthermore, easy, robust and quick image registration can provide real-time white-light and fluorescence imaging guidance in lung cancer surgery.
The purpose of this study was to analyse our experience with 2 different NIR devices: the SUPEREYE system by Key Laboratory of Molecular Imaging, Chinese Academy of Science and the D-Light P system by Karl Storz Company, in pulmonary resection surgeries. We found that ICG-fluorescent imaging has the potential to detect small subclinical lung nodules. In this pilot study, we recruited 36 patients and reported the results of tumour imaging in NIR fluorescence image-guided lung cancer thoracoscopic surgery.
MATERIALS AND METHODS

Fluorescence thoracoscopic system
The SUPEREYE is a fluorescence thoracoscopic system developed for image-guided minimally invasive surgery. This system contains a colour imaging channel (400-650 nm) and a NIR fluorescence imaging channel (excitation: 785 ± 5 nm; emission: 840 ± 10 nm). Fluorescence imaging was designed especially for collecting the wavelength of ICG. We designed the system based on 3 aspects: (i) Image acquisition: a NIR light-optimum rigid clinical thoracoscope (HOPKINS II 26003BGA, Karl Storz, Tuttlingen, Germany) was used as system lens. The light collected from the lens is transmitted into a customized camera (Microview, Beijing, China). The camera contains 1 light splitter and 2 high-sensitivity and high-resolution camera chips for simultaneous colour and NIR fluorescence imaging. (ii) Illumination design: one 785-nm NIR excitation light source (MW-SGX-785, Changchun Lei Shi Optoelectronic Technology Co. Ltd, Changchun, Jilin, China) and one visible light source (XENON NOVA 300, Karl Storz) were coupled by a custom-made multimode bifurcated fibre bundle (Banglei Optoelectronic Technology Co. Ltd, Zhongshan, Guangdong, China) with small light coupling loss. (iii) Software development: the collected fluorescence and colour images can be accurately, quickly and robustly registered into merged images. The software simultaneously displays colour, fluorescence and merged images at a video rate. The spatial resolution of the system is 35 lm, and the sensitivity for ICG detection is 0.01 lm. We also used another commercial fluorescence thoracoscopic system to explore the feasibility of lung tumours detection: the D-Light P system (Karl Storz). This system sensitivity is 0.1 lm but currently it cannot simultaneously display colour and fluorescence images.
Patients
This study enrolled 36 patients (19 males and 17 females) who were scheduled for VATS pulmonary resection surgery in Peking University People's Hospital. The hospital's Institutional Review Board approved this study (2015PHB157-01), and all patients signed the informed consents. We also registered this clinical trial at ClinicalTrials.gov (NCT02611245). All patients had one or more pulmonary nodules diagnosed by chest high-resolution computed tomography (CT) with 0.1 cm slice thickness. Patients who had ICG allergy were excluded.
Imaging procedure
Intraoperative lung cancer thoracoscopic surgery was guided by traditional white-light imaging and ICG-fluorescent imaging. Figure  1 illustrates the NIR fluorescence imaging-guided lung cancer surgery. Patients were administered ICG (Yichuang Pharmaceutical Limited Liability Company, Dandong, China) at a dose of 5 mg/kg according to patients' weight through a peripheral vein 24 h preoperatively [22] . The fluorescence thoracoscopic system was prepared and covered with a sterilized set. In the first step, surgeons located tumours according to a traditional standard operating procedure, which combined preoperative CT data and white-light thoracoscopy. In the next step, the detected lung nodules were subsequently investigated by the fluorescence thoracoscopic system. The colour, fluorescence and merged images of the nodules were simultaneously displayed and recorded at video rate. Meanwhile, we grossly examined the lung for extra subclinical tumour nodules detection in this procedure. All identified nodules were removed and marked for biopsies. The specimens were reviewed by 2 experienced pathologists (Kunkun Sun and Danhua Shen).
Analysis of fluorescence data
Fluorescence intensity of lung lesions was quantitatively analysed according to the recorded videos. The calculation method was as follows: we used an image processing software (ImageJ, National Institutes of Health, Bethesda, MD, USA) to delineate lung nodule as a region of interest (ROI), and then the software calculated the mean brightness value of ROI (B ROI ) within a range of 0-255. The background brightness (B Background ) was measured by calculating the mean brightness value of surrounding tissues. The signal-tobackground ratio (SBR) was calculated by dividing the B ROI by the B Background . Each nodule was evaluated 3 times to reduce errors.
Statistical analysis
To compare the fluorescence intensity differences obtained while using the 2 fluorescence imaging systems (SUPEREYE and D-Light P), we performed Student's t-tests. The analysis was performed using Prism software version 4.0 (San Diego, CA, USA). Twosample, one-way Student's t-tests were used to determine significant differences in the hypothesis that the SBR of SUPEREYE was higher than the SBR of D-Light P. If the P-value was <0.05, the SBR differences were considered to be valid.
RESULTS
Characteristics of lung nodules
From August 2015 to October 2016, we enrolled 36 patients (age 56 ± 14 years) in this study. In total, 76 nodules (size 1.4 ± 1.2 cm) were detected by combining traditional methods with ICGfluorescent imaging. From the 36 patients, 11 patients were diagnosed with metastasis from other cancers and 25 patients with non-small-cell lung cancer (NSCLC) ( Table 1) . We performed wedge resection in 14 patients, segmentectomy in 7 patients, lobectomy in 14 patients and pneumonectomy in 1 patient.
The ICG-fluorescent imaging method successfully identified 68 of the 76 nodules in vivo. The other 8 nodules that were located 1.3 cm or more beneath the pleural surface could not be detected. After excision and direct exposure of these nodules, all 76 nodules were fluorescent. Histology of these nodules showed that 71 pulmonary nodules were malignant and 5 nodules were false positive (hyperplasia and inflammation). The characteristics of the nodules are listed in Table 1 . The mean SBR of the nodules was 3.29 ± 1.81 (range: 1.43-11.9). The 2 NIR devices could high-sensitivity detect lung nodules in pulmonary resection surgery (Fig. 2) . We found that ICG-fluorescent imaging had a great imaging effect for squamous cell carcinoma (SBR: 4.08 ± 0.88) and pulmonary metastasis of hepatocellular carcinoma (HCC) (SBR: 6.09 ± 2.4). The mean SBR of adenocarcinoma nodules was 2.91. However, in some adenocarcinoma nodules, the SBR was as low as 1.43 and the contrast between the nodules and the surrounding tissues was less obvious. The sensitivities and positive predictive values of ICGfluorescent imaging for lung tumours were thus 88.7% (63 fluorescing lesions of the 71 malignant nodules) and 92.6% (63 cancers of the 68 fluorescing lesions), respectively.
Indocyanine green-fluorescent imaging can identify sub-centimetre lung nodules
Although preoperative imaging provided information on the location of small nodules, it remains a challenge to localize subcentimetre pulmonary nodules by VATS. To examine our experience of using ICG-fluorescent imaging to detect micro nodules, 2 NIR devices were used during surgery. For lung nodules with a size < _1 cm, the fluorescence signals were clearly demarcated from the surrounding normal tissues with a mean SBR of 3.14 ± 1.59. ICG-fluorescent images collected either by our selfdeveloped system (SBR: 3.83 ± 1.24) or by a commercial fluorescence thoracoscopic system (SBR: 3.11 ± 1.94) showed a significant tumour-to-surrounding tissue contrast compared with the traditional white-light imaging (Fig. 3) . Figure 2A -D shows the CT, colour, fluorescence and haematoxylin and eosin (H&E) of micro pulmonary nodules (adenocarcinoma, pulmonary metastases of HCC, breast cancer and colorectal cancer). Notably, all of these tumours were less than 1 cm.
Indocyanine green-fluorescent imaging can identify additional pulmonary nodules
Among the 76 nodules, 9 additional small lung nodules were detected only by the ICG-fluorescent imaging method in 7 of the 36 patients (19.4%). For the 9 nodules, 6 nodules were detected in different lobes than the primary tumours. The characteristics of these nodules are shown in Table 2 . These 9 lesions comprised 2 adenocarcinoma in situ, 2 atypical adenomatous hyperplasia, and 5 false-positive nodules (hyperplasia and inflammation). The representative frames of additional small nodules and the corresponding histopathological results are shown in Fig. 2E (white arrow). They were missed by traditional white-light thoracoscopic exploration and CT images. In contrast, ICG-fluorescent imaging showed the 3 additional synchronous nodules with high SBR (2.85 ± 0.11, 2.47 ± 0.14 and 2.25 ± 0.18). The tumour size were < _0.2 cm. Histology results of these nodules were atypical adenomatous hyperplasia and adenocarcinoma in situ (Fig. 2E) .
DISCUSSION
In the treatment of malignant lung nodules, the efficacy of surgical resection remains limited by the lack of real-time highsensitivity intraoperative imaging methods. Furthermore, incomplete resection results in postoperative recurrence of the malignancy. Therefore, the development of new high-sensitivity imaging methods, such as ICG-fluorescent imaging, shows great potential to detect additional subclinical nodules.
ICG is not a tumour-specific fluorescence dye, such as ligandspecific binding to tumour cell receptor, it accumulates in certain types of tumours because of the EPR effect [23] [24] [25] . The EPR effect is a passively accumulating effect due to the permeability effect of the nascent porous tumour blood vessels and the retention effect of dysfunctional tumour lymphatic system, which allows ICG to accumulate in tumour tissues. To obtain an optimal tumour-to-lung contrast, we have performed several preexperiments of injection dose and time of ICG. The results demonstrated that the optimum dose was 5 mg/kg and that the best injection time was 24 h preoperatively. In combination with ICG, fluorescence imaging provided high-contrast tumour images and increased additional tumour detection rate. Okusanya et al. first demonstrated ICG could be applied for lung nodules imaging and verified ICG-fluorescent imaging guided open surgery could detect additional pulmonary nodules. However, in the treatment of lung cancer by VATS, only a few research studies have explored the application of ICG-fluorescent imaging [26] , but the sensitivity and specificity of ICG-fluorescent image-guided lung cancer thoracoscopic surgery have not been studied.
More early stage lung cancer patients chose VATS as a superior alternative to open surgery due to minimal trauma, less bleeding and faster recovery, while the fluorescence thoracoscopic system applied in VATS was faced with a big challenge [27] . The poor NIRlight transmission and small apertures of the traditional white-light thoracoscope resulted in a massive light loss and low tumour-totissue contrast. Thus, many researchers have devoted themselves to developing high-sensitivity NIR fluorescence thoracoscopic systems. Venugopal et al. simultaneously optimized NIR fluorescence and colour imaging using a custom endoscope and a 2-charge-coupled device (CCD) camera [28] . Glatz et al. used a more sensitive electron-multiplying charge-coupled device camera to improve the NIR wavelength collection efficiencies [29] . In our case, we designed a fluorescence thoracoscopic system specially for ICG imaging. Its sensitivity for ICG imaging is about 10 times higher than that of the published fluorescence thoracoscopic system [28] . And we also used a commercial fluorescence imaging system (D-Light P) in this study.
The goal of our study was to validate our experience of using 2 different NIR devices, enabling high-sensitivity identification of sub-centimetre pulmonary nodules in VATS lung cancer surgery. For sub-centimetre lung nodules, the commercial D-Light P system showed a significant tumour-to-surrounding tissue contrast (SBR: 2.91 ± 1.62) compared with traditional white-light imaging. We found that ICG-fluorescent imaging had a higher SBR in squamous cell carcinoma and pulmonary metastasis of HCC than other lung tumours. The possible reason is that squamous cell carcinoma is an epithelial tumour that has both an exceptionally high endocytic rate and deficient tight junctions that lead to more ICG accumulating in cells. Furthermore, the HCC tumour cells expressed the membrane transporters' organic anion transporting polypeptide 1B3 and sodium-taurocholate co-transporting polypeptide, which mediates the cellular uptake of ICG [30] . A more detailed study would need to be performed to validate the relation between SBR and histopathology. Furthermore, our selfdeveloped SUPEREYE system has a higher SBR of 3.69 ± 1.37 than D-Light P (P < 0.05). For the detected 76 nodules, the sensitivities and positive predictive values of the ICG-fluorescent imaging were 88.7% and 92.6%. Eight pulmonary nodules embedded deeply in the lung were undetected by ICG-fluorescent imaging, and the maximized detection depth of ICG-fluorescent method was 1.3 cm. Future studies on fluorescence thoracoscopic systems should focus on developing deep tissue imaging with new imaging technologies, such as a second NIR imaging method (wavelength: 1100-1400 nm). Furthermore, we detected 4 additional positive nodules that were not revealed during standard surgical exploration. If these extra subclinical nodules were not resected, recurrence or metastasis of lung tumours might result in poor prognosis. Meanwhile, the extra resections were safe without obvious/prolong air leak. However, we also detected 5 additional false-positive nodules with the ICG-fluorescent imaging method. The histopathology results of these false-positive nodules were hyperplasia or inflammation. ICG as a non-specific fluorescence dye was diffused into tissues with hyperpermeable vascular structures by EPR effect, such as hyperplasia or inflammation. To reduce the false-positive results, surgeons could use alternative indications (inspection and palpation of nodules) to judge whether the fluorescence area should be removed or not. Targeted NIR probes that specifically bind lung tumour tissues have the potential to decrease false-positive nodules. Therefore, further studies will need to develop novel NIR targeting agents for increasing positive predictive values.
Currently, it is difficult to distinguish small multiple nodules from surrounding tissues via intraoperative white-light thoracoscopy, however, the ICG-fluorescent imaging method is good for sub-centimetre tumour detection. Therefore, by combining ICG-fluorescent imaging with preoperative CT data, the surgical exploration in pulmonary resections reveals the nodules located deeply in the lung and easily identifies sub-centimetre nodules. As a result, exploration time might be saved and the tumour detection rate might be improved. The next obvious step for us is to design a random, double-blind and multiple study to compare ICG-fluorescent imaging combining CT method with the traditional white-light imaging combining CT method for the detection of pulmonary nodules.
CONCLUSION
In conclusion, we believe we have validated that ICG-fluorescent imaging with 2 NIR devices enables high-sensitivity visualization of sub-centimetre pulmonary nodules. In addition, we showed that ICG-fluorescent imaging also has the potential to detect additional positive lesions. The identification of these nodules might reduce tumour recurrence, which has a remarkable clinical potential for application in lung cancer.
